Found 92 hits with Last Name = 'eckert' and Initial = 'wa' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
P2X purinoceptor 7
(Homo sapiens (Human)) | BDBM50191064
(CHEMBL3894220)Show SMILES Nc1ccc2c(C(=O)NCC(N3CCC(F)(F)CC3)c3cnc(nc3)C(F)(F)F)c(Cl)ccc2n1 Show InChI InChI=1S/C22H20ClF5N6O/c23-14-2-3-15-13(1-4-17(29)33-15)18(14)19(35)30-11-16(34-7-5-21(24,25)6-8-34)12-9-31-20(32-10-12)22(26,27)28/h1-4,9-10,16H,5-8,11H2,(H2,29,33)(H,30,35) | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutical Research& Development L.L.C.
Curated by ChEMBL
| Assay Description
Antagonist activity at human P2X7 receptor assessed as reduction in calcium flux by FLIPR assay |
Bioorg Med Chem Lett 26: 4781-4784 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.029
BindingDB Entry DOI: 10.7270/Q2QJ7K7G |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
(Homo sapiens (Human)) | BDBM50419064
(CHEMBL1823874)Show SMILES CCOc1ccccc1C(=O)NCC1(CCCCC1)N1CCN(CC1)C(C)C Show InChI InChI=1S/C23H37N3O2/c1-4-28-21-11-7-6-10-20(21)22(27)24-18-23(12-8-5-9-13-23)26-16-14-25(15-17-26)19(2)3/h6-7,10-11,19H,4-5,8-9,12-18H2,1-3H3,(H,24,27) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 15.8 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN1 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
P2X purinoceptor 7
(Homo sapiens (Human)) | BDBM50190913
(CHEMBL3912682)Show SMILES FC(F)(F)c1ncc(cn1)C(CNC(=O)c1c(Cl)ccc2nc(ccc12)N1CCOCC1)N1CCC(F)(F)CC1 Show InChI InChI=1S/C26H26ClF5N6O2/c27-18-2-3-19-17(1-4-21(36-19)38-9-11-40-12-10-38)22(18)23(39)33-15-20(37-7-5-25(28,29)6-8-37)16-13-34-24(35-14-16)26(30,31)32/h1-4,13-14,20H,5-12,15H2,(H,33,39) | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutical Research& Development L.L.C.
Curated by ChEMBL
| Assay Description
Antagonist activity at human P2X7 receptor assessed as reduction in calcium flux by FLIPR assay |
Bioorg Med Chem Lett 26: 4781-4784 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.029
BindingDB Entry DOI: 10.7270/Q2QJ7K7G |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
(Homo sapiens (Human)) | BDBM50419067
(CHEMBL1823878)Show InChI InChI=1S/C22H35N3O2/c1-3-24-14-16-25(17-15-24)22(12-8-5-9-13-22)18-23-21(26)19-10-6-7-11-20(19)27-4-2/h6-7,10-11H,3-5,8-9,12-18H2,1-2H3,(H,23,26) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN1 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
(Homo sapiens (Human)) | BDBM50419065
(CHEMBL1823875)Show InChI InChI=1S/C22H35N3O2/c1-18(2)24-13-15-25(16-14-24)22(11-7-4-8-12-22)17-23-21(26)19-9-5-6-10-20(19)27-3/h5-6,9-10,18H,4,7-8,11-17H2,1-3H3,(H,23,26) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN1 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4
(Homo sapiens (Human)) | BDBM50419053
(CHEMBL2052019 | ZD-7288)Show InChI InChI=1S/C15H20N4/c1-5-19(13-9-7-6-8-10-13)15-11-14(16-3)18(4)12(2)17-15/h6-11H,5H2,1-4H3/p+1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN4 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
P2X purinoceptor 7
(Homo sapiens (Human)) | BDBM50190797
(CHEMBL3974590)Show SMILES O[C@@H]1CCN(C1)c1ccc2c(C(=O)NCC(N3CCC(F)(F)CC3)c3cnc(nc3)C(F)(F)F)c(Cl)ccc2n1 |r| Show InChI InChI=1S/C26H26ClF5N6O2/c27-18-2-3-19-17(1-4-21(36-19)38-8-5-16(39)14-38)22(18)23(40)33-13-20(37-9-6-25(28,29)7-10-37)15-11-34-24(35-12-15)26(30,31)32/h1-4,11-12,16,20,39H,5-10,13-14H2,(H,33,40)/t16-,20?/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutical Research& Development L.L.C.
Curated by ChEMBL
| Assay Description
Antagonist activity at human P2X7 receptor assessed as reduction in calcium flux by FLIPR assay |
Bioorg Med Chem Lett 26: 4781-4784 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.029
BindingDB Entry DOI: 10.7270/Q2QJ7K7G |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
(Homo sapiens (Human)) | BDBM50419068
(CHEMBL1823879)Show SMILES CCOc1ccccc1C(=O)NCC1(CCCCC1)N1CCN(CC1)C1CC1 Show InChI InChI=1S/C23H35N3O2/c1-2-28-21-9-5-4-8-20(21)22(27)24-18-23(12-6-3-7-13-23)26-16-14-25(15-17-26)19-10-11-19/h4-5,8-9,19H,2-3,6-7,10-18H2,1H3,(H,24,27) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 50.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN1 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
P2X purinoceptor 7
(Homo sapiens (Human)) | BDBM50190804
(CHEMBL3966074)Show SMILES FC(F)(F)c1ncc(cn1)C(CNC(=O)c1c(Cl)ccc2nc(NC3CC3)ccc12)N1CCC(F)(F)CC1 Show InChI InChI=1S/C25H24ClF5N6O/c26-17-4-5-18-16(3-6-20(36-18)35-15-1-2-15)21(17)22(38)32-13-19(37-9-7-24(27,28)8-10-37)14-11-33-23(34-12-14)25(29,30)31/h3-6,11-12,15,19H,1-2,7-10,13H2,(H,32,38)(H,35,36) | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 64 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutical Research& Development L.L.C.
Curated by ChEMBL
| Assay Description
Antagonist activity at human P2X7 receptor assessed as reduction in calcium flux by FLIPR assay |
Bioorg Med Chem Lett 26: 4781-4784 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.029
BindingDB Entry DOI: 10.7270/Q2QJ7K7G |
More data for this
Ligand-Target Pair | |
P2X purinoceptor 7
(Homo sapiens (Human)) | BDBM50191067
(CHEMBL3963395)Show SMILES OCCNc1ccc2c(C(=O)NCC(N3CCC(F)(F)CC3)c3cnc(nc3)C(F)(F)F)c(Cl)ccc2n1 Show InChI InChI=1S/C24H24ClF5N6O2/c25-16-2-3-17-15(1-4-19(35-17)31-7-10-37)20(16)21(38)32-13-18(36-8-5-23(26,27)6-9-36)14-11-33-22(34-12-14)24(28,29)30/h1-4,11-12,18,37H,5-10,13H2,(H,31,35)(H,32,38) | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 78 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutical Research& Development L.L.C.
Curated by ChEMBL
| Assay Description
Antagonist activity at human P2X7 receptor assessed as reduction in calcium flux by FLIPR assay |
Bioorg Med Chem Lett 26: 4781-4784 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.029
BindingDB Entry DOI: 10.7270/Q2QJ7K7G |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
(Homo sapiens (Human)) | BDBM50419069
(CHEMBL1823880)Show SMILES CCOc1ccccc1C(=O)NCC1(CCCCC1)N1CCN(CC1)C1CCC1 Show InChI InChI=1S/C24H37N3O2/c1-2-29-22-12-5-4-11-21(22)23(28)25-19-24(13-6-3-7-14-24)27-17-15-26(16-18-27)20-9-8-10-20/h4-5,11-12,20H,2-3,6-10,13-19H2,1H3,(H,25,28) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 79.4 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN1 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
P2X purinoceptor 7
(Mus musculus) | BDBM50190797
(CHEMBL3974590)Show SMILES O[C@@H]1CCN(C1)c1ccc2c(C(=O)NCC(N3CCC(F)(F)CC3)c3cnc(nc3)C(F)(F)F)c(Cl)ccc2n1 |r| Show InChI InChI=1S/C26H26ClF5N6O2/c27-18-2-3-19-17(1-4-21(36-19)38-8-5-16(39)14-38)22(18)23(40)33-13-20(37-9-6-25(28,29)7-10-37)15-11-34-24(35-12-15)26(30,31)32/h1-4,11-12,16,20,39H,5-10,13-14H2,(H,33,40)/t16-,20?/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 80 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutical Research& Development L.L.C.
Curated by ChEMBL
| Assay Description
Antagonist activity at mouse P2X7 receptor assessed as reduction in calcium flux by FLIPR calcium flux assay |
Bioorg Med Chem Lett 26: 4781-4784 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.029
BindingDB Entry DOI: 10.7270/Q2QJ7K7G |
More data for this
Ligand-Target Pair | |
P2X purinoceptor 7
(Homo sapiens (Human)) | BDBM50190917
(CHEMBL3918589)Show SMILES CNc1ccc2c(C(=O)NCC(N3CCC(F)(F)CC3)c3cnc(nc3)C(F)(F)F)c(Cl)ccc2n1 Show InChI InChI=1S/C23H22ClF5N6O/c1-30-18-5-2-14-16(34-18)4-3-15(24)19(14)20(36)31-12-17(35-8-6-22(25,26)7-9-35)13-10-32-21(33-11-13)23(27,28)29/h2-5,10-11,17H,6-9,12H2,1H3,(H,30,34)(H,31,36) | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 82 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutical Research& Development L.L.C.
Curated by ChEMBL
| Assay Description
Antagonist activity at human P2X7 receptor assessed as reduction in calcium flux by FLIPR assay |
Bioorg Med Chem Lett 26: 4781-4784 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.029
BindingDB Entry DOI: 10.7270/Q2QJ7K7G |
More data for this
Ligand-Target Pair | |
P2X purinoceptor 7
(Homo sapiens (Human)) | BDBM50191061
(CHEMBL3893653)Show SMILES CN1CCN(CC1)c1ccc2c(C(=O)NCC(N3CCC(F)(F)CC3)c3cnc(nc3)C(F)(F)F)c(Cl)ccc2n1 Show InChI InChI=1S/C27H29ClF5N7O/c1-38-10-12-40(13-11-38)22-5-2-18-20(37-22)4-3-19(28)23(18)24(41)34-16-21(39-8-6-26(29,30)7-9-39)17-14-35-25(36-15-17)27(31,32)33/h2-5,14-15,21H,6-13,16H2,1H3,(H,34,41) | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 85 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutical Research& Development L.L.C.
Curated by ChEMBL
| Assay Description
Antagonist activity at human P2X7 receptor assessed as reduction in calcium flux by FLIPR assay |
Bioorg Med Chem Lett 26: 4781-4784 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.029
BindingDB Entry DOI: 10.7270/Q2QJ7K7G |
More data for this
Ligand-Target Pair | |
P2X purinoceptor 7
(Homo sapiens (Human)) | BDBM50190797
(CHEMBL3974590)Show SMILES O[C@@H]1CCN(C1)c1ccc2c(C(=O)NCC(N3CCC(F)(F)CC3)c3cnc(nc3)C(F)(F)F)c(Cl)ccc2n1 |r| Show InChI InChI=1S/C26H26ClF5N6O2/c27-18-2-3-19-17(1-4-21(36-19)38-8-5-16(39)14-38)22(18)23(40)33-13-20(37-9-6-25(28,29)7-10-37)15-11-34-24(35-12-15)26(30,31)32/h1-4,11-12,16,20,39H,5-10,13-14H2,(H,33,40)/t16-,20?/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 87 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutical Research& Development L.L.C.
Curated by ChEMBL
| Assay Description
Antagonist activity at P2X7 receptor in human whole blood assessed as reduction in LPS/BzATP-induced IL-1beta release preincubated with LPS-stimulate... |
Bioorg Med Chem Lett 26: 4781-4784 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.029
BindingDB Entry DOI: 10.7270/Q2QJ7K7G |
More data for this
Ligand-Target Pair | |
P2X purinoceptor 7
(Mus musculus) | BDBM50190913
(CHEMBL3912682)Show SMILES FC(F)(F)c1ncc(cn1)C(CNC(=O)c1c(Cl)ccc2nc(ccc12)N1CCOCC1)N1CCC(F)(F)CC1 Show InChI InChI=1S/C26H26ClF5N6O2/c27-18-2-3-19-17(1-4-21(36-19)38-9-11-40-12-10-38)22(18)23(39)33-15-20(37-7-5-25(28,29)6-8-37)16-13-34-24(35-14-16)26(30,31)32/h1-4,13-14,20H,5-12,15H2,(H,33,39) | PDB
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 103 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutical Research& Development L.L.C.
Curated by ChEMBL
| Assay Description
Antagonist activity at mouse P2X7 receptor assessed as reduction in calcium flux by FLIPR calcium flux assay |
Bioorg Med Chem Lett 26: 4781-4784 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.029
BindingDB Entry DOI: 10.7270/Q2QJ7K7G |
More data for this
Ligand-Target Pair | |
P2X purinoceptor 7
(Homo sapiens (Human)) | BDBM50191063
(CHEMBL3982581)Show SMILES OC1CCN(CC1)c1ccc2c(C(=O)NCC(N3CCC(F)(F)CC3)c3cnc(nc3)C(F)(F)F)c(Cl)ccc2n1 Show InChI InChI=1S/C27H28ClF5N6O2/c28-19-2-3-20-18(1-4-22(37-20)39-9-5-17(40)6-10-39)23(19)24(41)34-15-21(38-11-7-26(29,30)8-12-38)16-13-35-25(36-14-16)27(31,32)33/h1-4,13-14,17,21,40H,5-12,15H2,(H,34,41) | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutical Research& Development L.L.C.
Curated by ChEMBL
| Assay Description
Antagonist activity at human P2X7 receptor assessed as reduction in calcium flux by FLIPR assay |
Bioorg Med Chem Lett 26: 4781-4784 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.029
BindingDB Entry DOI: 10.7270/Q2QJ7K7G |
More data for this
Ligand-Target Pair | |
P2X purinoceptor 7
(Mus musculus) | BDBM50190804
(CHEMBL3966074)Show SMILES FC(F)(F)c1ncc(cn1)C(CNC(=O)c1c(Cl)ccc2nc(NC3CC3)ccc12)N1CCC(F)(F)CC1 Show InChI InChI=1S/C25H24ClF5N6O/c26-17-4-5-18-16(3-6-20(36-18)35-15-1-2-15)21(17)22(38)32-13-19(37-9-7-24(27,28)8-10-37)14-11-33-23(34-12-14)25(29,30)31/h3-6,11-12,15,19H,1-2,7-10,13H2,(H,32,38)(H,35,36) | PDB
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 123 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutical Research& Development L.L.C.
Curated by ChEMBL
| Assay Description
Antagonist activity at mouse P2X7 receptor assessed as reduction in calcium flux by FLIPR calcium flux assay |
Bioorg Med Chem Lett 26: 4781-4784 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.029
BindingDB Entry DOI: 10.7270/Q2QJ7K7G |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
(Homo sapiens (Human)) | BDBM50419080
(CHEMBL1823677)Show InChI InChI=1S/C21H33N3O2/c1-3-26-19-10-6-5-9-18(19)20(25)22-17-21(11-7-4-8-12-21)24-15-13-23(2)14-16-24/h5-6,9-10H,3-4,7-8,11-17H2,1-2H3,(H,22,25) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 126 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN1 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
P2X purinoceptor 7
(Homo sapiens (Human)) | BDBM50190804
(CHEMBL3966074)Show SMILES FC(F)(F)c1ncc(cn1)C(CNC(=O)c1c(Cl)ccc2nc(NC3CC3)ccc12)N1CCC(F)(F)CC1 Show InChI InChI=1S/C25H24ClF5N6O/c26-17-4-5-18-16(3-6-20(36-18)35-15-1-2-15)21(17)22(38)32-13-19(37-9-7-24(27,28)8-10-37)14-11-33-23(34-12-14)25(29,30)31/h3-6,11-12,15,19H,1-2,7-10,13H2,(H,32,38)(H,35,36) | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 141 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutical Research& Development L.L.C.
Curated by ChEMBL
| Assay Description
Antagonist activity at P2X7 receptor in human whole blood assessed as reduction in LPS/BzATP-induced IL-1beta release preincubated with LPS-stimulate... |
Bioorg Med Chem Lett 26: 4781-4784 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.029
BindingDB Entry DOI: 10.7270/Q2QJ7K7G |
More data for this
Ligand-Target Pair | |
P2X purinoceptor 7
(Homo sapiens (Human)) | BDBM50190911
(CHEMBL3903665)Show SMILES O[C@H]1CCN(C1)c1ccc2c(C(=O)NCC(N3CCC(F)(F)CC3)c3cnc(nc3)C(F)(F)F)c(Cl)ccc2n1 |r| Show InChI InChI=1S/C26H26ClF5N6O2/c27-18-2-3-19-17(1-4-21(36-19)38-8-5-16(39)14-38)22(18)23(40)33-13-20(37-9-6-25(28,29)7-10-37)15-11-34-24(35-12-15)26(30,31)32/h1-4,11-12,16,20,39H,5-10,13-14H2,(H,33,40)/t16-,20?/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 151 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutical Research& Development L.L.C.
Curated by ChEMBL
| Assay Description
Antagonist activity at human P2X7 receptor assessed as reduction in calcium flux by FLIPR assay |
Bioorg Med Chem Lett 26: 4781-4784 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.029
BindingDB Entry DOI: 10.7270/Q2QJ7K7G |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4
(Homo sapiens (Human)) | BDBM50419067
(CHEMBL1823878)Show InChI InChI=1S/C22H35N3O2/c1-3-24-14-16-25(17-15-24)22(12-8-5-9-13-22)18-23-21(26)19-10-6-7-11-20(19)27-4-2/h6-7,10-11H,3-5,8-9,12-18H2,1-2H3,(H,23,26) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 158 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN4 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
(Homo sapiens (Human)) | BDBM50419053
(CHEMBL2052019 | ZD-7288)Show InChI InChI=1S/C15H20N4/c1-5-19(13-9-7-6-8-10-13)15-11-14(16-3)18(4)12(2)17-15/h6-11H,5H2,1-4H3/p+1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 158 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN1 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
(Homo sapiens (Human)) | BDBM50419070
(CHEMBL1823881)Show SMILES CCOc1ccccc1C(=O)NCC1(CCCCC1)N1CCN(CC1)C1CCCC1 Show InChI InChI=1S/C25H39N3O2/c1-2-30-23-13-7-6-12-22(23)24(29)26-20-25(14-8-3-9-15-25)28-18-16-27(17-19-28)21-10-4-5-11-21/h6-7,12-13,21H,2-5,8-11,14-20H2,1H3,(H,26,29) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN1 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
(Homo sapiens (Human)) | BDBM50419066
(CHEMBL1823876)Show SMILES CC(C)Oc1ccccc1C(=O)NCC1(CCCCC1)N1CCN(CC1)C(C)C Show InChI InChI=1S/C24H39N3O2/c1-19(2)26-14-16-27(17-15-26)24(12-8-5-9-13-24)18-25-23(28)21-10-6-7-11-22(21)29-20(3)4/h6-7,10-11,19-20H,5,8-9,12-18H2,1-4H3,(H,25,28) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 251 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN1 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
P2X purinoceptor 7
(Mus musculus) | BDBM50190917
(CHEMBL3918589)Show SMILES CNc1ccc2c(C(=O)NCC(N3CCC(F)(F)CC3)c3cnc(nc3)C(F)(F)F)c(Cl)ccc2n1 Show InChI InChI=1S/C23H22ClF5N6O/c1-30-18-5-2-14-16(34-18)4-3-15(24)19(14)20(36)31-12-17(35-8-6-22(25,26)7-9-35)13-10-32-21(33-11-13)23(27,28)29/h2-5,10-11,17H,6-9,12H2,1H3,(H,30,34)(H,31,36) | PDB
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 305 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutical Research& Development L.L.C.
Curated by ChEMBL
| Assay Description
Antagonist activity at mouse P2X7 receptor assessed as reduction in calcium flux by FLIPR calcium flux assay |
Bioorg Med Chem Lett 26: 4781-4784 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.029
BindingDB Entry DOI: 10.7270/Q2QJ7K7G |
More data for this
Ligand-Target Pair | |
P2X purinoceptor 7
(Mus musculus) | BDBM50190797
(CHEMBL3974590)Show SMILES O[C@@H]1CCN(C1)c1ccc2c(C(=O)NCC(N3CCC(F)(F)CC3)c3cnc(nc3)C(F)(F)F)c(Cl)ccc2n1 |r| Show InChI InChI=1S/C26H26ClF5N6O2/c27-18-2-3-19-17(1-4-21(36-19)38-8-5-16(39)14-38)22(18)23(40)33-13-20(37-9-6-25(28,29)7-10-37)15-11-34-24(35-12-15)26(30,31)32/h1-4,11-12,16,20,39H,5-10,13-14H2,(H,33,40)/t16-,20?/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutical Research& Development L.L.C.
Curated by ChEMBL
| Assay Description
Antagonist activity at P2X7 receptor in C57/bl6 mouse whole blood assessed as reduction in LPS/BzATP-induced IL-1beta release preincubated with LPS-s... |
Bioorg Med Chem Lett 26: 4781-4784 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.029
BindingDB Entry DOI: 10.7270/Q2QJ7K7G |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4
(Homo sapiens (Human)) | BDBM50419068
(CHEMBL1823879)Show SMILES CCOc1ccccc1C(=O)NCC1(CCCCC1)N1CCN(CC1)C1CC1 Show InChI InChI=1S/C23H35N3O2/c1-2-28-21-9-5-4-8-20(21)22(27)24-18-23(12-6-3-7-13-23)26-16-14-25(15-17-26)19-10-11-19/h4-5,8-9,19H,2-3,6-7,10-18H2,1H3,(H,24,27) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 316 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN4 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4
(Homo sapiens (Human)) | BDBM50419064
(CHEMBL1823874)Show SMILES CCOc1ccccc1C(=O)NCC1(CCCCC1)N1CCN(CC1)C(C)C Show InChI InChI=1S/C23H37N3O2/c1-4-28-21-11-7-6-10-20(21)22(27)24-18-23(12-8-5-9-13-23)26-16-14-25(15-17-26)19(2)3/h6-7,10-11,19H,4-5,8-9,12-18H2,1-3H3,(H,24,27) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 316 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN4 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
(Homo sapiens (Human)) | BDBM50419085
(CHEMBL1823887)Show SMILES CCOc1ccccc1C(=O)NCC1(CCOCC1)N1CCN(CC1)C(C)C Show InChI InChI=1S/C22H35N3O3/c1-4-28-20-8-6-5-7-19(20)21(26)23-17-22(9-15-27-16-10-22)25-13-11-24(12-14-25)18(2)3/h5-8,18H,4,9-17H2,1-3H3,(H,23,26) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 316 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN1 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
P2X purinoceptor 7
(Homo sapiens (Human)) | BDBM50190913
(CHEMBL3912682)Show SMILES FC(F)(F)c1ncc(cn1)C(CNC(=O)c1c(Cl)ccc2nc(ccc12)N1CCOCC1)N1CCC(F)(F)CC1 Show InChI InChI=1S/C26H26ClF5N6O2/c27-18-2-3-19-17(1-4-21(36-19)38-9-11-40-12-10-38)22(18)23(39)33-15-20(37-7-5-25(28,29)6-8-37)16-13-34-24(35-14-16)26(30,31)32/h1-4,13-14,20H,5-12,15H2,(H,33,39) | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 376 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutical Research& Development L.L.C.
Curated by ChEMBL
| Assay Description
Antagonist activity at P2X7 receptor in human whole blood assessed as reduction in LPS/BzATP-induced IL-1beta release preincubated with LPS-stimulate... |
Bioorg Med Chem Lett 26: 4781-4784 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.029
BindingDB Entry DOI: 10.7270/Q2QJ7K7G |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
(Homo sapiens (Human)) | BDBM50419055
(CHEMBL1823666)Show SMILES CCOc1ccccc1C(=O)NCC1(Cc2ccccc2C1)N1CCN(C)CC1 Show InChI InChI=1S/C24H31N3O2/c1-3-29-22-11-7-6-10-21(22)23(28)25-18-24(27-14-12-26(2)13-15-27)16-19-8-4-5-9-20(19)17-24/h4-11H,3,12-18H2,1-2H3,(H,25,28) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 398 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN1 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
(Homo sapiens (Human)) | BDBM50419062
(CHEMBL1435630)Show InChI InChI=1S/C20H31N3O2/c1-22-12-14-23(15-13-22)20(10-6-3-7-11-20)16-21-19(24)17-8-4-5-9-18(17)25-2/h4-5,8-9H,3,6-7,10-16H2,1-2H3,(H,21,24) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 398 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN1 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
(Homo sapiens (Human)) | BDBM50419083
(CHEMBL1823882)Show InChI InChI=1S/C20H31N3O2/c1-2-25-18-9-5-4-8-17(18)19(24)22-16-20(10-6-3-7-11-20)23-14-12-21-13-15-23/h4-5,8-9,21H,2-3,6-7,10-16H2,1H3,(H,22,24) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 398 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN1 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
(Homo sapiens (Human)) | BDBM50419074
(CHEMBL1823886)Show InChI InChI=1S/C20H31N3O2/c1-3-25-18-9-5-4-8-17(18)19(24)21-16-20(10-6-7-11-20)23-14-12-22(2)13-15-23/h4-5,8-9H,3,6-7,10-16H2,1-2H3,(H,21,24) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 398 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN1 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
P2X purinoceptor 7
(Mus musculus) | BDBM50191061
(CHEMBL3893653)Show SMILES CN1CCN(CC1)c1ccc2c(C(=O)NCC(N3CCC(F)(F)CC3)c3cnc(nc3)C(F)(F)F)c(Cl)ccc2n1 Show InChI InChI=1S/C27H29ClF5N7O/c1-38-10-12-40(13-11-38)22-5-2-18-20(37-22)4-3-19(28)23(18)24(41)34-16-21(39-8-6-26(29,30)7-9-39)17-14-35-25(36-15-17)27(31,32)33/h2-5,14-15,21H,6-13,16H2,1H3,(H,34,41) | PDB
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 486 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutical Research& Development L.L.C.
Curated by ChEMBL
| Assay Description
Antagonist activity at mouse P2X7 receptor assessed as reduction in calcium flux by FLIPR calcium flux assay |
Bioorg Med Chem Lett 26: 4781-4784 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.029
BindingDB Entry DOI: 10.7270/Q2QJ7K7G |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
(Homo sapiens (Human)) | BDBM50419060
(CHEMBL1823674)Show SMILES CCOc1ccccc1C(=O)NCC1(Cc2ccccc2C1)N1CCN(CC1)C(C)C Show InChI InChI=1S/C26H35N3O2/c1-4-31-24-12-8-7-11-23(24)25(30)27-19-26(17-21-9-5-6-10-22(21)18-26)29-15-13-28(14-16-29)20(2)3/h5-12,20H,4,13-19H2,1-3H3,(H,27,30) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 631 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN1 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
(Homo sapiens (Human)) | BDBM50419078
(CHEMBL1823667)Show SMILES CN1CCN(CC1)C1(CNC(=O)c2ccccc2OCc2ccccc2)Cc2ccccc2C1 Show InChI InChI=1S/C29H33N3O2/c1-31-15-17-32(18-16-31)29(19-24-11-5-6-12-25(24)20-29)22-30-28(33)26-13-7-8-14-27(26)34-21-23-9-3-2-4-10-23/h2-14H,15-22H2,1H3,(H,30,33) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 631 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN1 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
(Homo sapiens (Human)) | BDBM50419075
(CHEMBL1823888)Show SMILES COc1ccccc1C(=O)NCC1(CCN(CC1)c1ccccc1)N1CCN(CC1)C(C)C Show InChI InChI=1S/C27H38N4O2/c1-22(2)29-17-19-31(20-18-29)27(13-15-30(16-14-27)23-9-5-4-6-10-23)21-28-26(32)24-11-7-8-12-25(24)33-3/h4-12,22H,13-21H2,1-3H3,(H,28,32) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 631 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN1 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
P2X purinoceptor 7
(Mus musculus) | BDBM50190913
(CHEMBL3912682)Show SMILES FC(F)(F)c1ncc(cn1)C(CNC(=O)c1c(Cl)ccc2nc(ccc12)N1CCOCC1)N1CCC(F)(F)CC1 Show InChI InChI=1S/C26H26ClF5N6O2/c27-18-2-3-19-17(1-4-21(36-19)38-9-11-40-12-10-38)22(18)23(39)33-15-20(37-7-5-25(28,29)6-8-37)16-13-34-24(35-14-16)26(30,31)32/h1-4,13-14,20H,5-12,15H2,(H,33,39) | PDB
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 631 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutical Research& Development L.L.C.
Curated by ChEMBL
| Assay Description
Antagonist activity at P2X7 receptor in C57/bl6 mouse whole blood assessed as reduction in LPS/BzATP-induced IL-1beta release preincubated with LPS-s... |
Bioorg Med Chem Lett 26: 4781-4784 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.029
BindingDB Entry DOI: 10.7270/Q2QJ7K7G |
More data for this
Ligand-Target Pair | |
P2X purinoceptor 7
(Mus musculus) | BDBM50190804
(CHEMBL3966074)Show SMILES FC(F)(F)c1ncc(cn1)C(CNC(=O)c1c(Cl)ccc2nc(NC3CC3)ccc12)N1CCC(F)(F)CC1 Show InChI InChI=1S/C25H24ClF5N6O/c26-17-4-5-18-16(3-6-20(36-18)35-15-1-2-15)21(17)22(38)32-13-19(37-9-7-24(27,28)8-10-37)14-11-33-23(34-12-14)25(29,30)31/h3-6,11-12,15,19H,1-2,7-10,13H2,(H,32,38)(H,35,36) | PDB
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 631 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutical Research& Development L.L.C.
Curated by ChEMBL
| Assay Description
Antagonist activity at P2X7 receptor in C57/bl6 mouse whole blood assessed as reduction in LPS/BzATP-induced IL-1beta release preincubated with LPS-s... |
Bioorg Med Chem Lett 26: 4781-4784 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.029
BindingDB Entry DOI: 10.7270/Q2QJ7K7G |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4
(Homo sapiens (Human)) | BDBM50419069
(CHEMBL1823880)Show SMILES CCOc1ccccc1C(=O)NCC1(CCCCC1)N1CCN(CC1)C1CCC1 Show InChI InChI=1S/C24H37N3O2/c1-2-29-22-12-5-4-11-21(22)23(28)25-19-24(13-6-3-7-14-24)27-17-15-26(16-18-27)20-9-8-10-20/h4-5,11-12,20H,2-3,6-10,13-19H2,1H3,(H,25,28) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 794 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN4 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4
(Homo sapiens (Human)) | BDBM50419070
(CHEMBL1823881)Show SMILES CCOc1ccccc1C(=O)NCC1(CCCCC1)N1CCN(CC1)C1CCCC1 Show InChI InChI=1S/C25H39N3O2/c1-2-30-23-13-7-6-12-22(23)24(29)26-20-25(14-8-3-9-15-25)28-18-16-27(17-19-28)21-10-4-5-11-21/h6-7,12-13,21H,2-5,8-11,14-20H2,1H3,(H,26,29) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 794 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN4 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4
(Homo sapiens (Human)) | BDBM50419065
(CHEMBL1823875)Show InChI InChI=1S/C22H35N3O2/c1-18(2)24-13-15-25(16-14-24)22(11-7-4-8-12-22)17-23-21(26)19-9-5-6-10-20(19)27-3/h5-6,9-10,18H,4,7-8,11-17H2,1-3H3,(H,23,26) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 794 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN4 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
P2X purinoceptor 7
(Mus musculus) | BDBM50191064
(CHEMBL3894220)Show SMILES Nc1ccc2c(C(=O)NCC(N3CCC(F)(F)CC3)c3cnc(nc3)C(F)(F)F)c(Cl)ccc2n1 Show InChI InChI=1S/C22H20ClF5N6O/c23-14-2-3-15-13(1-4-17(29)33-15)18(14)19(35)30-11-16(34-7-5-21(24,25)6-8-34)12-9-31-20(32-10-12)22(26,27)28/h1-4,9-10,16H,5-8,11H2,(H2,29,33)(H,30,35) | PDB
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 1.09E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutical Research& Development L.L.C.
Curated by ChEMBL
| Assay Description
Antagonist activity at mouse P2X7 receptor assessed as reduction in calcium flux by FLIPR calcium flux assay |
Bioorg Med Chem Lett 26: 4781-4784 (2016)
Article DOI: 10.1016/j.bmcl.2016.08.029
BindingDB Entry DOI: 10.7270/Q2QJ7K7G |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
(Homo sapiens (Human)) | BDBM50419054
(CHEMBL1823665)Show SMILES COc1ccccc1C(=O)NCC1(Cc2ccccc2C1)N1CCN(C)CC1 Show InChI InChI=1S/C23H29N3O2/c1-25-11-13-26(14-12-25)23(15-18-7-3-4-8-19(18)16-23)17-24-22(27)20-9-5-6-10-21(20)28-2/h3-10H,11-17H2,1-2H3,(H,24,27) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.26E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN1 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4
(Homo sapiens (Human)) | BDBM50419080
(CHEMBL1823677)Show InChI InChI=1S/C21H33N3O2/c1-3-26-19-10-6-5-9-18(19)20(25)22-17-21(11-7-4-8-12-21)24-15-13-23(2)14-16-24/h5-6,9-10H,3-4,7-8,11-17H2,1-2H3,(H,22,25) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.26E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN4 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
(Homo sapiens (Human)) | BDBM50419084
(CHEMBL1823885)Show SMILES COc1ccccc1C(=O)NCC1(CCc2ccccc2C1)N1CCN(C)CC1 Show InChI InChI=1S/C24H31N3O2/c1-26-13-15-27(16-14-26)24(12-11-19-7-3-4-8-20(19)17-24)18-25-23(28)21-9-5-6-10-22(21)29-2/h3-10H,11-18H2,1-2H3,(H,25,28) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.58E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN1 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4
(Homo sapiens (Human)) | BDBM50419066
(CHEMBL1823876)Show SMILES CC(C)Oc1ccccc1C(=O)NCC1(CCCCC1)N1CCN(CC1)C(C)C Show InChI InChI=1S/C24H39N3O2/c1-19(2)26-14-16-27(17-15-26)24(12-8-5-9-13-24)18-25-23(28)21-10-6-7-11-22(21)29-20(3)4/h6-7,10-11,19-20H,5,8-9,12-18H2,1-4H3,(H,25,28) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.58E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN4 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
(Homo sapiens (Human)) | BDBM50419076
(CHEMBL1823889)Show InChI InChI=1S/C22H29N3O2/c1-17-8-10-18(11-9-17)20(25-14-12-24(2)13-15-25)16-23-22(26)19-6-4-5-7-21(19)27-3/h4-11,20H,12-16H2,1-3H3,(H,23,26) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 2.51E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
| Assay Description
Inhibition of human HCN1 heterologously expressed in HEK-293 cells after 30 mins by VIPR assay |
Bioorg Med Chem Lett 21: 5197-201 (2011)
Article DOI: 10.1016/j.bmcl.2011.07.051
BindingDB Entry DOI: 10.7270/Q2PV6MNP |
More data for this
Ligand-Target Pair | |
Search and Browse
